A New Tool Is Added to the COVID-19 Armamentarium

The United States Food and Drug Administration has given the green light to a pill, made by Pfizer, designed to treat COVID-19.  The oral antiviral medication is the first of its kind to gain approval for the treatment of SARS-CoV-2 infection. A clinical study conducted by Pfizer demonstrated that the medication, called Paxlovid, was effective at decreasing the risk of hospitalization as well as death among those most vulnerable to severe COVID-19 illness. The medication regimen must begin within 3 days of symptoms emerging, and is taken twice per day for 5 days. Click here to read more.